Cargando…

Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters

BACKGROUND. Outcomes of liver transplantation (LT) from donation after circulatory death (DCD) have been improving; however, ischemic cholangiopathy (IC) continues to be a problem. In 2014, measures to minimize donor hepatectomy time (DHT) and cold ischemic time (CIT) have been adopted to improve DC...

Descripción completa

Detalles Bibliográficos
Autores principales: Goussous, Naeem, Alvarez-Casas, Josue, Dawany, Noor, Xie, Wen, Malik, Saad, Gray, Stephen H., Barth, Rolf N., LaMattina, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710320/
https://www.ncbi.nlm.nih.gov/pubmed/34966844
http://dx.doi.org/10.1097/TXD.0000000000001277
_version_ 1784623125883781120
author Goussous, Naeem
Alvarez-Casas, Josue
Dawany, Noor
Xie, Wen
Malik, Saad
Gray, Stephen H.
Barth, Rolf N.
LaMattina, John C.
author_facet Goussous, Naeem
Alvarez-Casas, Josue
Dawany, Noor
Xie, Wen
Malik, Saad
Gray, Stephen H.
Barth, Rolf N.
LaMattina, John C.
author_sort Goussous, Naeem
collection PubMed
description BACKGROUND. Outcomes of liver transplantation (LT) from donation after circulatory death (DCD) have been improving; however, ischemic cholangiopathy (IC) continues to be a problem. In 2014, measures to minimize donor hepatectomy time (DHT) and cold ischemic time (CIT) have been adopted to improve DCD LT outcomes. METHODS. Retrospective review of all patients who underwent DCD LT between 2005 and 2017 was performed. We compared outcomes of patients who were transplanted before 2014 (historic group) with those who were transplanted between 2014 and 2017 (modern group). RESULTS. We identified 112 patients; 44 were in the historic group and 68 in the modern group. Donors in the historic group were younger (26.5 versus 33, P = 0.007) and had a lower body mass index (26.2 versus 28.2, P = 0.007). DHT (min) and CIT (h) were significantly longer in the historic group (21.5 versus 14, P < 0.001 and 5.3 versus 4.2, P < 0.001, respectively). Fourteen patients (12.5%) developed IC, with a significantly higher incidence in the historic group (23.3% versus 6.1%, P = 0.02). There was no difference in graft and patient survival between both groups. CONCLUSION. In appropriately selected recipients, minimization of DHT and CIT may decrease the incidence of IC. These changes can potentially expand the DCD donor pool.
format Online
Article
Text
id pubmed-8710320
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-87103202021-12-28 Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters Goussous, Naeem Alvarez-Casas, Josue Dawany, Noor Xie, Wen Malik, Saad Gray, Stephen H. Barth, Rolf N. LaMattina, John C. Transplant Direct Liver Transplantation BACKGROUND. Outcomes of liver transplantation (LT) from donation after circulatory death (DCD) have been improving; however, ischemic cholangiopathy (IC) continues to be a problem. In 2014, measures to minimize donor hepatectomy time (DHT) and cold ischemic time (CIT) have been adopted to improve DCD LT outcomes. METHODS. Retrospective review of all patients who underwent DCD LT between 2005 and 2017 was performed. We compared outcomes of patients who were transplanted before 2014 (historic group) with those who were transplanted between 2014 and 2017 (modern group). RESULTS. We identified 112 patients; 44 were in the historic group and 68 in the modern group. Donors in the historic group were younger (26.5 versus 33, P = 0.007) and had a lower body mass index (26.2 versus 28.2, P = 0.007). DHT (min) and CIT (h) were significantly longer in the historic group (21.5 versus 14, P < 0.001 and 5.3 versus 4.2, P < 0.001, respectively). Fourteen patients (12.5%) developed IC, with a significantly higher incidence in the historic group (23.3% versus 6.1%, P = 0.02). There was no difference in graft and patient survival between both groups. CONCLUSION. In appropriately selected recipients, minimization of DHT and CIT may decrease the incidence of IC. These changes can potentially expand the DCD donor pool. Lippincott Williams & Wilkins 2021-12-23 /pmc/articles/PMC8710320/ /pubmed/34966844 http://dx.doi.org/10.1097/TXD.0000000000001277 Text en Copyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Liver Transplantation
Goussous, Naeem
Alvarez-Casas, Josue
Dawany, Noor
Xie, Wen
Malik, Saad
Gray, Stephen H.
Barth, Rolf N.
LaMattina, John C.
Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters
title Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters
title_full Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters
title_fullStr Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters
title_full_unstemmed Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters
title_short Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters
title_sort ischemic cholangiopathy postdonation after circulatory death liver transplantation: donor hepatectomy time matters
topic Liver Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710320/
https://www.ncbi.nlm.nih.gov/pubmed/34966844
http://dx.doi.org/10.1097/TXD.0000000000001277
work_keys_str_mv AT goussousnaeem ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters
AT alvarezcasasjosue ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters
AT dawanynoor ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters
AT xiewen ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters
AT maliksaad ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters
AT graystephenh ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters
AT barthrolfn ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters
AT lamattinajohnc ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters